Review ArticleClinical Review

MALAdaptive: Do We Avoid Metformin Unnecessarily?

Chris Terpening
The Journal of the American Board of Family Medicine January 2014, 27 (1) 136-141; DOI: https://doi.org/10.3122/jabfm.2014.01.120173

References

  1. 1.↵
    CDC's Division of Diabetes Translation. Long-term trends in diagnosed diabetes. Atlanta: Centers for Disease Control; 2011. Available from: http://www.cdc.gov/diabetes/statistics/slides/long_term_trends.pdf. Accessed November 8, 2013.
  2. 2.↵
    1. Inzucchi SE,
    2. Bergenstal RM,
    3. Buse JB,
    4. et al
    . Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Diabetes Care 2012;35:1364–79.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Handelsman Y,
    2. Mechanick J,
    3. Blonde L,
    4. et al
    . American Association of Clinical Endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract 2011;17:287–302.
    OpenUrlCrossRefPubMed
  4. 4.↵
    UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–65.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Holman RR,
    2. Paul SK,
    3. Bethel MA,
    4. Matthews DR,
    5. Neil HAW
    . 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577–89.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Metformin package insert. Princeton, NJ: Bristol-Myers Squibb; 2008.
  7. 7.↵
    1. Luft D,
    2. Deichsel G,
    3. Schmulling R,
    4. Stein W,
    5. Eggstein M
    . Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol 1983;80:484–9.
    OpenUrlPubMedWeb of Science
  8. 8.↵
    1. Stacpoole PW,
    2. Wright EC,
    3. Baumgartner TG,
    4. et al
    . Natural history and course of acquired lactic acidosis in adults. Am J Med 1994;97:47–54.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. McCormack J,
    2. Johns K,
    3. Tildesley H
    . Metformin's contraindications should be contraindicated. CMAJ 2005;173:502–4.
    OpenUrlFREE Full Text
  10. 10.↵
    1. Heaf JG,
    2. van Biesen W
    . Metformin and chronic renal impairment: a story of choices and ugly ducklings. Clin Diabetes 2011;29:97–101.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Holstein A,
    2. Stumvoll M
    . Contraindications can damage your health—is metformin a case in point? Diabetologia 2005;48:2454–59.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Philbrick AM,
    2. Ernst ME,
    3. McDanel DL,
    4. Ross MB,
    5. Moores KG
    . Metformin use in renal dysfunction: is a serum creatinine threshold appropriate? Am J Health Syst Pharm 2009;66:2017–22.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Lalau J-D
    . Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf 2010;33:727–40.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Salpeter SR,
    2. Greyber E,
    3. Pasternak GA,
    4. Salpeter EE
    . Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010;(4):CD002967.
  15. 15.↵
    1. Duong JK,
    2. Roberts DM,
    3. Furlong TJ,
    4. et al
    . Metformin therapy in patients with chronic kidney disease. Diabetes Obes Metab 2012;14:963–65.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Wills BK,
    2. Bryant SM,
    3. Buckley P,
    4. Seo B
    . Can acute overdose of metformin lead to lactic acidosis? Am J Emerg Med 2010;28:857–61.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Lalau JD,
    2. Mourlhon C,
    3. Bergeret A,
    4. Lacroix C
    . Consequences of metformin intoxication. Diabetes Care 1998;21:2036–7.
    OpenUrlFREE Full Text
  18. 18.↵
    1. Stades AME,
    2. Heikens JT,
    3. Erkelens DW,
    4. Holleman F,
    5. Hoekstra JBL
    . Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med 2004;255:179–87.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. van Berlo-van de Laar IRF,
    2. Vermeij CG,
    3. Doorenbos CJ
    . Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. J Clin Pharm Ther 2011;36:376–82.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Duong JK,
    2. Furlong TJ,
    3. Roberts DM,
    4. et al
    . The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis. Drug Saf 2013 Apr 3. [Epub ahead of print]
  21. 21.↵
    1. Kajbaf F,
    2. Lalau J-D
    . The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis. BMC Pharm Toxicol 2013;14:22.
    OpenUrl
  22. 22.↵
    1. Seidowsky A,
    2. Nseir S,
    3. Houdret N,
    4. Fourrier F
    . Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009;37:2191–6.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Lalau J-D,
    2. Race JM
    . Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999;20:377–84.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Friesecke S,
    2. Abel P,
    3. Roser M,
    4. Felix S,
    5. Runge S
    . Outcome of severe lactic acidosis associated with metformin accumulation. Crit Care 2010;14:R226.
    OpenUrlPubMed
  25. 25.↵
    1. Peters N,
    2. Jay N,
    3. Barraud D,
    4. et al
    . Metformin-associated lactic acidosis in an intensive care unit. Crit Care 2008;12:R149.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Renda F,
    2. Mura P,
    3. Finco G,
    4. Ferrazin F,
    5. Pani L,
    6. Landoni G
    . Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci 2013;17(Suppl 1):45–9.
    OpenUrlPubMed
  27. 27.↵
    1. Kajbaf F,
    2. Lalau JD
    . The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database. Diabet Med 2013;30:345–8.
    OpenUrlPubMed
  28. 28.↵
    1. Brown JB,
    2. Pedula K,
    3. Barzilay J,
    4. Herson MK,
    5. Latare P
    . Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998;21:1659–63.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Cryer DR,
    2. Nicholas SP,
    3. Henry DH,
    4. Mills DJ,
    5. Stadel BV
    . Comparative outcomes study of metformin intervention versus conventional approach: The COSMIC Approach Study. Diabetes Care 2005;28:539–43.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Bodmer M,
    2. Meier C,
    3. Krähenbühl S,
    4. Jick SS,
    5. Meier CR
    . Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia. Diabetes Care 2008;31:2086–91.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Kamber N,
    2. Davis WA,
    3. Bruce DG,
    4. Davis TME
    . Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study. Med J Austr 2008;188:446–9.
    OpenUrl
  32. 32.↵
    1. Stang M,
    2. Wysowski DK,
    3. Butler-Jones D
    . Incidence of lactic acidosis in metformin users. Diabetes Care 1999;22:925–7.
    OpenUrlAbstract
  33. 33.↵
    1. Scott KA,
    2. Martin JH,
    3. Inder WJ
    . Acidosis in the hospital setting: is metformin a common precipitant? Intern Med J 2010;40:342–6.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Scale T,
    2. Harvey JN
    . Diabetes, metformin and lactic acidosis. Clin Endocrinol 2011;74:191–6.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Hloch O,
    2. Charvat J,
    3. Masopust J,
    4. Havlin J
    . Lactic acidosis in medical ICU–the role of diabetes mellitus and metformin. Neuro Endocrinol Lett 2012;33:792–5.
    OpenUrlPubMed
  36. 36.↵
    1. Bruijstens LA,
    2. van Luin M,
    3. Buscher-Jungerhans PM,
    4. Bosch FH
    . Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment. Neth J Med 2008;66:185–90.
    OpenUrlPubMedWeb of Science
  37. 37.↵
    1. Vecchio S,
    2. Protti A
    . Metformin-induced lactic acidosis: no one left behind. Crit Care 2011;15:107.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Emslie-Smith AM,
    2. Boyle DIR,
    3. Evans JMM,
    4. Sullivan F,
    5. Morris AD
    ; DARTS/MEMO Collaboration. Contraindications to metformin therapy in patients with Type 2 diabetes—a population-based study of adherence to prescribing guidelines. Diabet Med 2001;18:483–8.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Pongwecharak J,
    2. Tengmeesri N,
    3. Malanusorn N,
    4. Panthong M,
    5. Pawangkapin N
    . Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome Pharm World Sci 2009;31:481–6.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Tahrani AA,
    2. Varughese GI,
    3. Scarpello JH,
    4. Hanna FWF
    . Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ 2007;335:508–12.
    OpenUrlFREE Full Text
  41. 41.↵
    1. Meyers JL,
    2. Candrilli SD,
    3. Kovacs B
    . Type 2 diabetes mellitus and renal impairment in a large outpatient electronic medical records database: rates of diagnosis and antihyperglycemic medication dose adjustment. Postgrad Med 2011;123:133–43.
    OpenUrlPubMed
  42. 42.↵
    1. Rachmani R,
    2. Slavachevski I,
    3. Levi Z,
    4. Zadok B-S,
    5. Kedar Y,
    6. Ravid M
    . Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications. Eur J Intern Med 2002;13:428–33.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Roussel R,
    2. Travert F,
    3. Pasquet B,
    4. et al
    . Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 2010;170:1892–9.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Ekström N,
    2. Schiöler L,
    3. Svensson A-M,
    4. et al
    . Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open 2012;2:e001076.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords